// App-Quantinova.ai

736 : Weekly bolus 5-fluorouracil and bevacizumab in the palliative treatment of metastatic colorectal cancer.

Researchers

Presenter

  • Michelle Jane Cook

Principal Investigators

  • Carole Connor

  • Mohammed Mojid Khan

  • Peter Denzil Correa

Medical Centers

  • University Hospitals Coventry and Warwickshire NHS Trust, Coventry, United Kingdom

  • University Hospitals Coventry and Warwickshire NHS Trust, Coventry, United Kingdom

  • University Hospitals Coventry and Warwickshire NHS Trust, Coventry, United Kingdom

  • University Hospitals Coventry, Warwickshire NHS Trust, South Warwickshire Hospitals NHS Foundation Trust, Coventry, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

  • Gastroenterology (GU)

Disease

  • Colorectal Cancer

Biomarkers

  • N/A

Drug/Treatment

  • Adrucil injection

  • Capecitabine

  • Bevacizumab

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A